News

Sevoflurane, also called fluoromethyl hexafluoroisopropyl ether, is an inhalation anesthetic, non-flammable, highly fluorinated methyl isopropyl ether used for induction and maintenance of general anesthesia. Together with desflurane, it

The financing will fund the company into 2010 and will be primarily used to drive product development of the company’s initial clinical target, diabetic retinopathy. Under the terms

Under the agreement, Stiefel Laboratories will purchase all of the outstanding shares of Barrier Therapeutics at a price of $4.15 per share in cash, representing a 73% premium

NanoGuardian said that its NanoEncryption technology provides pharmaceutical manufacturers with true forensic, multi-layered, authentication and tracing brand protection at the individual dosage level. NanoGuardian’s NanoEncryption technology works directly

The integrated offering will enable clinical trial patient images to be tracked and managed from within the InForm integrated trial management system, said Phase Forward. The joint solution

Under the terms of the alliance, Ascend Therapeutics will initiate promotion of the product in the US in June 2008. Ascend has a 50-person women’s health sales force

New England Research Institutes (NERI) said that its assessment of the outcomes in the treatment of abdominal aortic aneurysms demonstrated that the Talent abdominal stent graft’s primary safety

The multi-country, randomized, double-blind, controlled trial will enroll up to 200 breast cancer patients receiving four cycles of myelosuppressive CTX chemotherapy (doxorubicin 60mg/m2/docetaxel 75mg/m2). The study will compare

The agreement includes at least $87 million in product development and sales milestone payments to Emisphere, of which $10 million will be the minimum first year payment, as